Pressor Response to Noradrenaline in the Setting of Septic Shock: Anything New under the Sun-Dexmedetomidine, Clonidine? A Minireview

BioMed Research International
A GéloënL Quintin

Abstract

Progress over the last 50 years has led to a decline in mortality from ≈70% to ≈20% in the best series of patients with septic shock. Nevertheless, refractory septic shock still carries a mortality close to 100%. In the best series, the mortality appears related to multiple organ failure linked to comorbidities and/or an intense inflammatory response: shortening the period that the subject is exposed to circulatory instability may further lower mortality. Treatment aims at reestablishing circulation within a "central" compartment (i.e., brain, heart, and lung) but fails to reestablish a disorganized microcirculation or an adequate response to noradrenaline, the most widely used vasopressor. Indeed, steroids, nitric oxide synthase inhibitors, or donors have not achieved overwhelming acceptance in the setting of septic shock. Counterintuitively, α 2-adrenoceptor agonists were shown to reduce noradrenaline requirements in two cases of human septic shock. This has been replicated in rat and sheep models of sepsis. In addition, some data show that α 2-adrenoceptor agonists lead to an improvement in the microcirculation. Evidence-based documentation of the effects of alpha-2 agonists is needed in the setting of human septic shock.

References

Aug 1, 1978·The Journal of Surgical Research·F B CerraJ H Siegel
Nov 1, 1983·The Journal of Physiology·J ButlerF Pidgeon
Jan 1, 1994·Cardiovascular Research·A PetrosP Vallance
Sep 1, 1993·Critical Care Medicine·J A LorenteD Liste
Apr 29, 1998·Critical Care Medicine·J A AvontuurH A Bruining
Jan 8, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J E HungerfordS S Segal
Jun 14, 2000·American Journal of Respiratory and Critical Care Medicine·J L VincentJ C Preiser
Oct 3, 2000·Clinical Pharmacology and Therapeutics·E Bellissant, D Annane
Oct 6, 2001·Critical Care Medicine·M Y KirovL J Bjertnaes
Dec 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·Christopher G EllisRavi Gill
Jul 2, 2002·American Journal of Respiratory and Critical Care Medicine·Daniel De BackerJean-Louis Vincent
Nov 9, 2002·Lancet·Peter E SpronkDurk F Zandstra
Dec 21, 2002·Critical Care : the Official Journal of the Critical Care Forum·Mitchell P Fink
Sep 18, 2004·Intensive Care Medicine·Antoine Vieillard-BaronFrançois Jardin
Jan 11, 2005·Lancet·Djillali AnnaneJean-Marc Cavaillon
Apr 5, 2005·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Steven S Segal
Oct 20, 2006·The New England Journal of Medicine·James A Russell
Jun 19, 2007·Intensive Care Medicine·Jacques CreteurJean-Louis Vincent
Jan 11, 2008·The New England Journal of Medicine·Charles L SprungUNKNOWN CORTICUS Study Group
Apr 2, 2008·Critical Care Medicine·Daniel TalmorNathan Shapiro
Jun 17, 2009·Intensive Care Medicine·A Vieillard-BaronF Jardin
Jun 19, 2009·Critical Care : the Official Journal of the Critical Care Forum·Arnaldo DubinCan Ince
Aug 26, 2009·Journal of Intensive Care Medicine·Martin W Dünser, Walter R Hasibeder
Sep 4, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Rohit RamchandraClive N May
Mar 12, 2010·Intensive Care Medicine·Gustavo Ospina-TasconDaniel De Backer
Jul 17, 2010·Annales Françaises D'anesthèsie Et De Rèanimation·J-Y LefrantUNKNOWN Sepsi d'Oc study Group in the AzuRéa Group
Sep 8, 2010·Medical Hypotheses·C PichotL Quintin
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Oct 10, 2013·Critical Care : the Official Journal of the Critical Care Forum·Martin W DünserJan Bakker
Mar 19, 2014·The New England Journal of Medicine·Pierre AsfarUNKNOWN SEPSISPAM Investigators
Apr 11, 2015·Critical Care Medicine·Yugeesh R LankadevaClive N May
Jun 17, 2015·Critical Care Medicine·Ilse Gradwohl-Matis, Martin W Dünser

❮ Previous
Next ❯

Citations

Jun 19, 2018·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Niina KleiberSaskia N de Wildt
Feb 9, 2019·The American Journal of Sports Medicine·Dimitrios KitridisPanagiotis Givissis
Jul 18, 2020·Critical Care : the Official Journal of the Critical Care Forum·Luca CioccariUNKNOWN ANZICS Clinical Trials Group and the SPICE III Investigators
Jun 6, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wei ZhaoChang-Chun Cao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.